PhUSE EU Connect 2019

10th – 13th November 2019, Amsterdam, The Netherlands

We will attend to PhUSE EU Connect 2019. Meet us!

Amsterdam is undoubtedly one of the most well-known cities in the world. It has a strong tradition as a centre of culture and commerce and is a major hub for business, tourism, culture and renowned cuisine delicacies.

The conference venue, RAI Amsterdam, is located in Zuidas business district, or the ‘Financial Mile’. It lies between the Rivers Amstel and Schinkel, close to both the historic city centre and Amsterdam Airport Schiphol.

2019 marks PhUSE’s 15th year, and we will be reflecting upon the Society’s journey and celebrating the achievements to date. As an organisation, PhUSE has continually evolved, and strived to try different things for the benefit of the community. The focus of the first conferences ranged from the software used to the use of standards, moving to present-day topics such as patient centricity, data transparency and machine learning.

We will also be looking ahead to the ever-changing landscape, and the implications for the industry, as well as the challenges and benefits which this presents. Looking beneath the tip of the clinical trial iceberg, we will be discussing and debating topics such as patient recruitment, electronic health records, the Cloud, collaboration, analytical software and remote trials.


Read more about PhUSE EU Connect 2019


ACTide by nubilaria at Phuse EU Connect 2019


ACTide by nubilaria at Phuse EU Connect 2019


ACTide by nubilaria at Phuse EU Connect 2019


ACTide by nubilaria at Phuse EU Connect 2019

Latest news

ACTide by Nubilaria against COVID-19

DECEIVER trial for COVID-19 related ARDS intensive care

Read more
Nubilaria for EUROLogin2020


Read more
Nubilaria ACTide @ SCOPE Virtual 2021

SCOPE – Summit for Clinical Ops Executives

Read more
Nubilaria Christmas wishes 2020

Merry Christmas and Happy new Year

Read more

Want more information about our solutions?
Contact us today.

I've read and accept theTerms and Conditions and the Privacy Policy
   I would like to receive information about products and services via traditional mail, telephone, email and automated communication systems